Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries-Nile reported a decline of 5% in net profits for the fiscal year 2014/2015, as it reached EGP 18 million compared with EGP 17.13 million for the previous year.
The company's gross profit slide 35.1% to EGP 21.58 million in FY14/15, down from EGP 33.24 million for the preceding year.
The drug firm recorded net profits of around EGP 10.3 million in the first eleven months of FY14/15, compared to EGP 12.9 million for the same period of FY13/14.
